Open Access<p>Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells</p>
Author(s) -
Yi Shen,
Jicheng Tantai
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s275123
Subject(s) - in vivo , pharmacology , chemistry , gefitinib , in vitro , drug delivery , cytotoxicity , plga , zeta potential , drug , cancer cell , nanoparticle , cancer , medicine , nanotechnology , biochemistry , materials science , receptor , biology , epidermal growth factor receptor , microbiology and biotechnology , organic chemistry
This study aims to develop a novel co-delivery gefitinib and quercetin system loaded with PLGA-PEG nanoparticles and evaluate their antitumor activity in vitro and in vivo.